Catalase overexpression prevents nuclear factor erythroid 2-related factor 2 stimulation of renal angiotensinogen gene expression, hypertension, and kidney injury in diabetic mice

Diabetes

Volumn 63, Issue 10, 2014, Pages 3483-3496

  Abdo, Shaaban ^a   Shi, Yixuan ^a   Otoukesh, Abouzar ^a   Ghosh, Anindya ^a   Lo, Chao Sheng ^a   Chenier, Isabelle ^a   Filep, Janos G ^b   Ingelfinger, Julie R ^c   Zhang, Shao Ling ^a   Chan, John S D ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; ANGIOTENSINOGEN; CATALASE; GLUCOSE; HEME OXYGENASE 1; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 14; OLTIPRAZ; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR NRF2; TRIGONELLINE; NFE2L2 PROTEIN, MOUSE; PYRAZINE DERIVATIVE; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVITY; GENE DELETION; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; GLUCOSE BLOOD LEVEL; HYPERTENSION; KIDNEY INJURY; KIDNEY PROXIMAL TUBULE; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PLASMID; PROMOTER REGION; PROTEIN BLOOD LEVEL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYSTOLIC BLOOD PRESSURE; TRANSGENIC MOUSE; ACUTE KIDNEY FAILURE; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; GENETICS; METABOLISM; SIGNAL TRANSDUCTION;

ACUTE KIDNEY INJURY; ANGIOTENSINOGEN; ANIMALS; BLOOD GLUCOSE; CATALASE; DIABETES MELLITUS, EXPERIMENTAL; GENE EXPRESSION; HYPERTENSION; KIDNEY TUBULES, PROXIMAL; MICE; MICE, TRANSGENIC; NF-E2-RELATED FACTOR 2; NF-KAPPA B; PYRAZINES; REVERSE TRANSCRIPTASE INHIBITORS; SIGNAL TRANSDUCTION;

EID: 84907486499     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db13-1830     Document Type: Article

References (48)

1. Dzau VJ, Ingelfinger JR. Molecular biology and pathophysiology of the intrarenal renin-angiotensin system. J Hypertens Suppl 1989;7:S3-S8
2. Zhang SL, Filep JG, Hohman TC, Tang SS, Ingelfinger JR, Chan JS. Molecular mechanisms of glucose action on angiotensinogen gene expression in rat proximal tubular cells. Kidney Int 1999;55:454-464
3. Zhang SL, Tang SS, Chen X, Filep JG, Ingelfinger JR, Chan JS. High levels of glucose stimulate angiotensinogen gene expression via the P38 mitogenactivated protein kinase pathway in rat kidney proximal tubular cells. Endocrinology 2000;141:4637-4646
4. Hsieh TJ, Zhang SL, Filep JG, Tang SS, Ingelfinger JR, Chan JS. High glucose stimulates angiotensinogen gene expression via reactive oxygen species generation in rat kidney proximal tubular cells. Endocrinology 2002;143:2975-2985
5. Hsieh TJ, Fustier P, Zhang SL, et al. High glucose stimulates angiotensinogen gene expression and cell hypertrophy via activation of the hexosamine biosynthesis pathway in rat kidney proximal tubular cells. Endocrinology 2003; 144:4338-4349
6. Sachetelli S, Liu Q, Zhang SL, et al. RAS blockade decreases blood pressure and proteinuria in transgenic mice overexpressing rat angiotensinogen gene in the kidney. Kidney Int 2006;69:1016-1023
7. Liu F, Brezniceanu ML, Wei CC, et al. Overexpression of angiotensinogen increases tubular apoptosis in diabetes. J Am Soc Nephrol 2008;19:269-280
8. Lo CS, Liu F, Shi Y, et al. Dual RAS blockade normalizes angiotensinconverting enzyme-2 expression and prevents hypertension and tubular apoptosis in Akita angiotensinogen-transgenic mice. Am J Physiol Renal Physiol 2012;302:F840-F852
9. Liu F, Wei CC, Wu SJ, et al. Apocynin attenuates tubular apoptosis and tubulointerstitial fibrosis in transgenic mice independent of hypertension. Kidney Int 2009;75:156-166
10. Godin N, Liu F, Lau GJ, et al. Catalase overexpression prevents hypertension and tubular apoptosis in angiotensinogen transgenic mice. Kidney Int 2010;77: 1086-1097
11. Brezniceanu ML, Liu F, Wei CC, et al. Catalase overexpression attenuates angiotensinogen expression and apoptosis in diabetic mice. Kidney Int 2007;71 : 912-923
12. Brezniceanu ML, Liu F, Wei CC, et al. Attenuation of interstitial fibrosis and tubular apoptosis in db/db transgenic mice overexpressing catalase in renal proximal tubular cells. Diabetes 2008;57:451-459
13. Shi Y, Lo C-S, Chenier I, et al. Overexpression of catalase prevents hypertension and tubulointerstitial fibrosis and normalization of renal angiotensinconverting enzyme-2 expression in Akita mice. Am J Physiol Renal Physiol 2013; 304:F1335-F1346
14. Surh YJ, Kundu JK, Na HK. Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals. Planta Med 2008;74:1526-1539
15. Motohashi H, Yamamoto M. Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol Med 2004;10:549-557
16. Venugopal R, Jaiswal AK. Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene. Proc Natl Acad Sci U S A 1996; 93:14960-14965
17. Wang L, Lei C, Zhang SL, et al. Synergistic effect of dexamethasone and isoproterenol on the expression of angiotensinogen in immortalized rat proximal tubular cells. Kidney Int 1998;53:287-295
18. Ding Y, Sigmund CD. Androgen-dependent regulation of human angiotensinogen expression in KAP-hAGT transgenic mice. Am J Physiol Renal Physiol 2001;280:F54-F60
19. Abdo S, Lo CS, Chenier I, et al. Heterogeneous nuclear ribonucleoproteins F and K mediate insulin inhibition of renal angiotensinogen gene expression and prevention of hypertension and kidney injury in diabetic mice. Diabetologia 2013; 56:1649-1660
20. Chan K, Lu R, Chang JC, Kan YW. NRF2, a member of the NFE2 family of transcription factors, is not essential for murine erythropoiesis, growth, and development. Proc Natl Acad Sci U S A 1996;93:13943-13948
21. Chen X, Zhang SL, Pang L, et al. Characterization of a putative insulinresponsive element and its binding protein(s) in rat angiotensinogen gene promoter: Regulation by glucose and insulin. Endocrinology 2001;142:2577-2585
22. Qi Z, Fujita H, Jin J, et al. Characterization of susceptibility of inbred mouse strains to diabetic nephropathy. Diabetes 2005;54:2628-2637
23. Aleksunes LM, Reisman SA, Yeager RL, Goedken MJ, Klaassen CD. Nuclear factor erythroid 2-related factor 2 deletion impairs glucose tolerance and exacerbates hyperglycemia in type 1 diabetic mice. J Pharmacol Exp Ther 2010; 333:140-151
24. Arlt A, Sebens S, Krebs S, et al. Inhibition of the Nrf2 transcription factor by the alkaloid trigonelline renders pancreatic cancer cells more susceptible to apoptosis through decreased proteasomal gene expression and proteasome activity. Oncogene 2013;32:4825-4835
25. Diebold I, Petry A, Hess J, Görlach A. The NADPH oxidase subunit N0X4 is a new target gene of the hypoxia-inducible factor-1. Mol Biol Cell 2010;21:2087-2096
26. Ingelfinger JR, Jung F, Diamant D, et al. Rat proximal tubule cell line transformed with origin-defective SV40 DNA: Autocrine ANG II feedback. Am J Physiol 1999;276:F218-F227
27. Yoshioka M, Kayo T, Ikeda T, Koizumi A. A novel locus, Mody4, distal to D7MH89 on chromosome 7 determines early-on set NIDDM in nonobese C57BL/6 (Akita) mutant mice. Diabetes 1997;46:887-894
28. Haseyama T, Fujita T, Hirasawa F, et al. Complications of IgA nephropathy in a non-insulin-dependent diabetes model, the Akita mouse. Tohoku J Exp Med 2002;198:233-244
29. Lai KN, Leung JCK, Lai KB, To WY, Yeung VTF, Lai FMM. Gene expression of the renin-angiotensin system in human kidney. J Hypertens 1998;16:91-102
30. Navar LG, Harrison-Bernard LM, Nishiyama A, Kobori H. Regulation of intrarenal angiotensin II in hypertension. Hypertension 2002;39:316-322
31. Saito T, Urushihara M, Kotan i Y, Kagami S, Kobori H. Increased urinary angiotensinogen is precedent to increased urinary albumin in patients with type 1 diabetes. Am J Med Sci 2009;338:478-480
32. Kobori H, Urushihara M, Xu JH, Berenson GS, Navar LG. Urinary angiotensinogen is correlated with blood pressure in men (Bogalusa Heart Study). J Hypertens 2010;28:1422-1428
33. Navar LG, Prieto MC, Satou R, Kobori H. Intrarenal angiotensin II and its contribution to the genesis of chronic hypertension. Curr Opin Pharmacol 2011; 11:180-186
34. Celik S, Akkaya H. Total antioxidant capacity, catalase and superoxide dismutase on rats before and after diabetes. J Anim Vet Adv 2009;8:1503-1508
35. Takemoto K, Tanaka M, Iwata H, et al. Low catalase activity in blood is associated with the diabetes caused by alloxan. Clin Chim Acta 2009;407:43-46
36. Ungvari Z, Bailey-Downs L, Gautam T, et al. Adaptive induction of NF-E2-related factor-2-driven antioxidant genes in endothelial cells in response to hyperglycemia. Am J Physiol Heart Circ Physiol 2011;300:H1133-H1140
37. Kwak MK, Itoh K, Yamamoto M, Kensler TW. Enhanced expression of the transcription factor Nrf2 by cancer chemopreventive agents: Role of antioxidant response element-like sequences in the nrf2 promoter. Mol Cell Biol 2002;22: 2883-2892
38. Chan JSD, Chan AHH, Jiang Q, Nie ZR, LaChance S, Carrière S. Molecular cloning and expression of the rat angiotensinogen gene. Pediatr Nephrol 1990;4: 429-435
39. Gong P, Hu B, Cederbaum AI. Diallyl sulfide induces heme oxygenase-1 through MAPK pathway. Arch Biochem Biophys 2004;432:252-260
40. Shan Y, Wang X, Wang W, He C, Bao Y. p38 MAPK plays a distinct role in sulforaphane-induced up-regulation of ARE-dependent enzymes and downregulation of COX-2 in human bladder cancer cells. Oncol Rep 2010;23:1133-1138
41. Chen XQ, Wu SH, Zhou Y, Tang YR. Lipoxin A4-induced heme oxygenase-1 protects cardiomyocytes against hypoxia/reoxygenation injury via p38 MAPK activation and Nrf2/ARE complex. PLoS One 2013;8:e67120
42. Yu M, Li H, Liu Q, et al. Nuclear factor p65 interacts with Keap1 to repress the Nrf2-ARE pathway. Cell Signal 2011;23:883-892
43. Liu GH, Qu J, Shen X. NF-kappaB/p65 antagonizes Nrf2-ARE pathway by depriving CBP from Nrf2 and facilitating recruitment of HDAC3 to MafK. Biochim Biophys Acta 2008;1783:713-727
44. Saha PK, Reddy VT, Konopleva M, Andreeff M, Chan L. The triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic-acid methyl ester has potent anti-diabetic effects in diet-induced diabetic mice and Lepr(db/db) mice. J Biol Chem 2010;285: 40581-40592
45. Chin M, Lee CY, Chuang JC, et al. Bardoxolone methyl analogs RTA 405 and dh404 are well tolerated and exhibit efficacy in rodent models of type 2 diabetes and obesity. Am J Physiol Renal Physiol 2013;304:F1438-F1446
46. Zoja C, Corna D, Nava V, et al. Analogs of bardoxolone methyl worsen diabetic nephropathy in rats with additional adverse effects. Am J Physiol Renal Physiol 2013;304:F808-F819
47. Pergola PE, Raskin P, Toto RD, et al.; BEAM Study Investigators. Bardoxolone methyl and kidney function in CKD with type 2 diabetes. N Engl J Med 2011;365:327-336
48. de Zeeuw D, Akizawa T, Audhya P, et al.; BEACON Trial Investigators. Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease. N Engl J Med 2013;369:2492-2503